Cardiff Oncology, Inc. (CRDF) vs Spero Therapeutics, Inc. (SPRO)

• Cardiff Oncology, Inc. CRDF 0.78 ▲ +2.63%
• Spero Therapeutics, Inc. SPRO 1.04 ▲ +1.96%

Cardiff Oncology, Inc. and Spero Therapeutics, Inc. are both Biotechnology companies. Cardiff Oncology, Inc. and Spero Therapeutics, Inc. are of similar size ($59.4M and $58.8M). Cardiff Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; Spero Therapeutics, Inc. trades at 7.4×. Spero Therapeutics, Inc. grew revenue faster over the last twelve months: 37.2% against −6.79%. Spero Therapeutics, Inc. has the higher net margin (0.00% vs −7,889.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Spero Therapeutics, Inc. leads on 15 and Cardiff Oncology, Inc. on 0.